SINOPHARM (01099) announced its performance for the first three quarters, with a net profit attributable to the parent company of approximately 5.307 billion yuan, an increase of 0.53% year-on-year.

07:24 27/10/2025

China National Pharmaceutical Group Corporation (01099) announced its performance for the first 9 months before 2025, with operating income of approximately 431.479 billion yuan, the same...

SINOPHARM (01099) announced its performance for the first 9 months before 2025. The operating income was approximately 431.479 billion yuan, a decrease of 2.47% year-on-year; the net profit attributable to the owners of the parent company was approximately 5.307 billion yuan, an increase of 0.53% year-on-year; basic earnings per share were 1.7 yuan.

HK Stock Market Move | CR BLDG MAT TEC (01313) drops more than 4% after earnings, cement sales for the third quarter are slightly smaller than the industry average, the cement main business is still under pressure.

UBS Group AG: Corporate cloud spending stable and healthy. Amazon.com, Inc. (AMZN.US), Alphabet Inc. Class C (GOOGL.US) and Microsoft Corporation (MSFT.US) will benefit.

HK Stock Market Move | Cryptocurrency concept stocks rise: SINOHOPE TECH (01611) up more than 12%, OKG TECH (01499) up more than 9%

UBS Group AG: Corporate cloud spending stable and healthy. Amazon.com, Inc. (AMZN.US), Alphabet Inc. Class C (GOOGL.US) and Microsoft Corporation (MSFT.US) will benefit.

HK Stock Market Move | Cryptocurrency concept stocks rise: SINOHOPE TECH (01611) up more than 12%, OKG TECH (01499) up more than 9%